- Home
- Products
Rozlytrek (Entrectinib)
Rozlytrek (Entrectinib)
- Medicine Name: Rozlytrek
- Generic Name: Entrectinib
- Dosage Form & Strength: Capsules – 100 mg and 200 mg
- Manufactured By: Genentech, Inc.
Rozlytrek is a kinase inhibitor approved for the treatment of:
- Adults with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive
- Adults and pediatric patients (≥12 years) with NTRK gene fusion-positive solid tumors without a known acquired resistance mutation, who have progressed on prior therapy or have no satisfactory alternative options
Recommended Dosage:
- ROS1-positive NSCLC (Adults): 600 mg orally once daily with or without food
- NTRK Fusion-Positive Tumors:
- Adults: 600 mg once daily
- Pediatric Patients (BSA-based):
- BSA ≥1.51 m²: 600 mg
- BSA 1.11–1.50 m²: 500 mg
- BSA 0.91–1.10 m²: 400 mg
- BSA ≥1.51 m²: 600 mg
- Continue until disease progression or unacceptable toxicity
Congestive Heart Failure: Monitor LVEF before and during treatment. Manage symptoms promptly.
CNS Effects: May include dizziness, cognitive changes, mood disturbance. Avoid hazardous activities if affected.
Fracture Risk: Monitor for signs of bone pain or mobility issues.
Liver Toxicity: Monitor AST/ALT levels biweekly during the first month, then monthly.
Hyperuricemia: Monitor serum uric acid. Initiate urate-lowering treatment if needed.
Pregnancy & Breastfeeding: May cause fetal harm. Use contraception during treatment and for 7 days after the last dose. Avoid breastfeeding during this period.
Documents Required to Import Rozlytrek to India:
- Valid prescription from a qualified physician
- Diagnostic reports supporting indication
- Government-issued ID of the patient
Order Confirmation:
Confirmed upon receipt of required documents and import permit, if applicable.
Availability:
Available through Global Rare Meds in Mumbai, Delhi, Chennai, Hyderabad, Bangalore, Kolkata, Ahmedabad, Pune, and other Indian cities. Also available for global export via Named Patient Supply (NPS) program.
To Order or Enquire Price:
- 📞 Call/WhatsApp: +91-99675 15602
- 📧 Email: info@globalraremeds.com
Global Rare Meds sources Rozlytrek from certified suppliers in the USA, Europe, Canada, and Australia. Every order is:
- Dispensed with prescription verification
- Checked and packed at our Ambernath Fulfillment Center
- Shipped with complete legal compliance and temperature safety
What is the generic name of Rozlytrek®?
Entrectinib
Who manufactures Rozlytrek®?
Genentech, Inc.
Is Rozlytrek® FDA approved?
Yes, approved on August 15, 2019
What forms are available?
Capsules: 100 mg and 200 mg
What conditions does it treat?
- ROS1-positive NSCLC
- NTRK fusion-positive solid tumors (Adult & Pediatric ≥12 years)
Common side effects?
Fatigue, nausea, dizziness, constipation, diarrhea, edema, cognitive issues, vision disorders, cough, and myalgia
What is the cost in India?
Prices vary. Contact +91-99675 15602 or email info@globalraremeds.com
Storage?
Store below 30°C (86°F) in original packaging
Is it safe to buy Rozlytrek online?
Yes, when purchased through a licensed WHO-GDP & ISO-certified importer like Global Rare Meds
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
